REPABAY-2 Tablets

Efficiency for Uncontrolled HbA1c


COMPOSITION: Repaglinide 2 mg Tablets


  • Type 2 Diabetes Mellitus





  • Class of medications: Antihyperglycemic agents known as meglitinides
  • A rapid-acting insulin secretagogue that normalizes postprandial glucose excursions in type 2 diabetes mellitus patients.
  • Reduces long-term cardiovascular complications of diabetes mellitus.
  • Reduces blood glucose by stimulating insulin release from pancreatic beta-cells.
  • Shows additive effects when used in combination with other oral antidiabetic agents.
  • Reduces fasting and postprandial hyperglycemia and the level of glycosylated hemoglobin (HbA 1c) in patients with T2DM.
  • Its rapid onset and relatively short duration of action allow for flexible meal schedules.
  • Equal efficacy to various sulphonylureas with a reduced risk of serious hypoglycemia and weight gain.